Home
About
Overview
Sharing Data
ORCID
Help
History (34)
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future.
MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance.
The role of EGFR inhibition in the treatment of non-small cell lung cancer.
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.
EphB4 as a therapeutic target in mesothelioma.
See All 34 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
EphB4 as a therapeutic target in mesothelioma.
EphB4 as a therapeutic target in mesothelioma. BMC Cancer. 2013 May 30; 13:269.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Cell Line, Tumor
Drug Delivery Systems
Fluorescent Antibody Technique
Humans
Immunohistochemistry
In Situ Nick-End Labeling
Male
Mesothelioma
Mice
Mice, Inbred BALB C
Pleural Neoplasms
Receptor, EphB4
Serum Albumin
Xenograft Model Antitumor Assays
authors with profiles
Ravi Salgia